CHICAGO-Tuesday 7 August 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Cushman & Wakefield plc (“Cushman & Wakefield”) today announced the closing of its initial public offering of 45,000,000 of its ordinary shares, at a price to the public of $17.00 per share. In connection with the initial public offering, the underwriters exercised in full their option to purchase an additional 6,750,000 ordinary shares from Cushman & Wakefield. As a result, the total initial public offering size was 51,750,000 shares. The shares are listed on the New York Stock Exchange and trade under the symbol “CWK.”

Cushman & Wakefield also announced the initial closing of a primary private placement investment by Vanke Service (HongKong) Co., Limited in an aggregate number of ordinary shares that will represent ownership of 4.9% of outstanding ordinary shares after giving effect to the initial public offering and the full exercise of the underwriters’ op ... Read more »

 • Strong start on underlying revenue and profitability led by Growth Drivers and Opex discipline

• Reported operating profit and EPS impacted by large transactions in Q1 FY2017: 106.3 billion yen one-time gain on the sale of Wako and 16.8 billion yen from the 2nd tranche of products sold to Teva JV. Operating profit excluding these items was +37.5%
Print

OSAKA, Japan-Thursday 2 August 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502):

Underlying Revenue growth +6.4% with growth in every region

    Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) displaying strong growth of +11.8% over prior year. Key products Entyvio (+34.1%) and Ninlaro (+43.3%) made important contributions to revenue growth.
    Underlying Revenue increased in every region, particularly the U.S. whic ... Read more »